Ovarian cancer is the most common cause of mortality in patients with gynecologic
malignancies. Advanced-stage high-grade serous carcinoma accounts for most ovarian …

Compared with high-grade serous carcinoma, low-grade serous carcinoma of the ovary or
peritoneum is a less frequent epithelial ovarian cancer type that is poorly sensitive to …

Opinion Statement Low grade serous carcinoma of the ovary has been delineated as a
separate entity from its counterpart high grade serous carcinoma of the ovary. Molecular …

Ovarian low-grade serous ovarian carcinoma (OvLGSCa) comprises a minority within the
heterogeneous group of ovarian carcinomas. Despite biological differences with their high …

Objective Since almost two decades standard 1st-line chemotherapy for advanced ovarian
cancer (AOC) has been a platinum/taxane combination. More recently, this general strategy …

Objectives Low grade serous ovarian carcinoma is a rare subtype of ovarian cancer with an
indolent and chemorefractory course. As such, treatment strategies among practitioners are …

Introduction This study examines patterns of clinical practice in the management of women
with advanced high-grade serous ovarian carcinoma (HGSC). Methods A total of 852 …

Ovarian cancer continues to have a high mortality rate despite therapeutic advances.
Traditionally, treatment has focused on surgery followed by systemic platinum-based …

Opinion statement Low-grade serous ovarian cancer (LGSOC) is a rare subtype of ovarian
cancer, accounting for approximately 10% of cases of serous ovarian cancer. Patients …

Low-grade serous carcinoma represents less than 10% of epithelial ovarian cancers, is
often diagnosed in younger women, and is associated with prolonged survival relative to …